BNP PARIBAS FINANCIAL MARKETS - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 77 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$215,363,000
+11.6%
9,011
-31.8%
0.00%
Q4 2020$192,924,000
-15.7%
13,214
-18.0%
0.00%
Q3 2020$228,719,000
-82.4%
16,107
-81.8%
0.00%
-100.0%
Q2 2020$1,302,570,000
+1753.7%
88,550
+419.2%
0.00%
Q1 2020$70,267,000
+84.8%
17,055
+115.7%
0.00%
Q4 2019$38,023,000
-25.4%
7,905
-6.0%
0.00%
Q3 2019$50,952,000
+28.0%
8,408
+37.1%
0.00%
Q2 2019$39,810,000
-48.0%
6,134
-43.2%
0.00%
Q1 2019$76,508,000
+83060.9%
10,791
+56694.7%
0.00%
Q4 2018$92,000
-99.3%
19
-99.0%
0.00%
Q3 2018$13,744,000
+5.0%
1,870
-8.9%
0.00%
Q2 2018$13,092,000
-78.3%
2,052
-81.5%
0.00%
Q1 2018$60,264,000
+34.0%
11,078
+2.7%
0.00%
Q4 2017$44,973,000
-14.3%
10,785
+97.8%
0.00%
Q3 2017$52,503,000
-23.3%
5,452
-5.7%
0.00%
Q2 2017$68,413,000
+366.1%
5,783
+405.1%
0.00%
Q1 2017$14,679,000
-24.0%
1,145
-27.4%
0.00%
Q4 2016$19,315,000
-39.2%
1,578
-41.3%
0.00%
Q3 2016$31,742,000
+135.7%
2,690
+73.8%
0.00%
Q2 2016$13,468,000
-78.3%
1,548
-80.6%
0.00%
Q4 2015$62,034,000
-11.0%
7,994
-9.7%
0.00%
Q3 2015$69,689,000
+119.4%
8,855
+152.6%
0.00%
Q2 2015$31,764,000
+148.4%
3,506
+255.9%
0.00%
Q1 2015$12,785,000
-47.9%
985
-64.0%
0.00%
Q3 2014$24,560,000
+835.6%
2,738
+1311.3%
0.00%
Q2 2014$2,625,000
-57.5%
194
-58.2%
0.00%
Q4 2013$6,176,000
-95.1%
464
-96.2%
0.00%
Q2 2013$125,276,00012,1040.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Opaleye Management Inc. 500,000$6,765,0005.83%
Gruss & Co., LLC 200,000$2,706,0003.07%
First Light Asset Management, LLC 150,076$2,031,0001.37%
Curi RMB Capital, LLC 1,032,369$13,968,0000.88%
Camber Capital Management LP 908,100$12,287,0000.80%
CADIAN CAPITAL MANAGEMENT, LP 887,500$12,008,0000.36%
PARNASSUS INVESTMENTS, LLC 2,118,127$28,658,0000.25%
Visium Asset Management, LP 786,468$10,641,0000.16%
PUTNAM INVESTMENTS LLC 5,198,367$70,333,0000.15%
Capital Impact Advisors, LLC 13,933$189,0000.14%
View complete list of GENMARK DIAGNOSTICS INC shareholders